Reapplix is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers. Reapplix was founded in 2008. Reapplix's headquarters is located in Birkerod, Capital Region, DK 3460.
There have been no acquisitions found related to Reapplix
Recent investment data cannot be found related to Reapplix